Cargando…
Early alterations of neurovascular unit in the retina in mouse models of tauopathy
The retina, as the only visually accessible tissue in the central nervous system, has attracted significant attention for evaluating it as a biomarker for neurodegenerative diseases. Yet, most of studies focus on characterizing the loss of retinal ganglion cells (RGCs) and degeneration of their axon...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992935/ https://www.ncbi.nlm.nih.gov/pubmed/33762004 http://dx.doi.org/10.1186/s40478-021-01149-y |
_version_ | 1783669475872079872 |
---|---|
author | Xia, Fan Ha, Yonju Shi, Shuizhen Li, Yi Li, Shengguo Luisi, Jonathan Kayed, Rakez Motamedi, Massoud Liu, Hua Zhang, Wenbo |
author_facet | Xia, Fan Ha, Yonju Shi, Shuizhen Li, Yi Li, Shengguo Luisi, Jonathan Kayed, Rakez Motamedi, Massoud Liu, Hua Zhang, Wenbo |
author_sort | Xia, Fan |
collection | PubMed |
description | The retina, as the only visually accessible tissue in the central nervous system, has attracted significant attention for evaluating it as a biomarker for neurodegenerative diseases. Yet, most of studies focus on characterizing the loss of retinal ganglion cells (RGCs) and degeneration of their axons. There is no integrated analysis addressing temporal alterations of different retinal cells in the neurovascular unit (NVU) in particular retinal vessels. Here we assessed NVU changes in two mouse models of tauopathy, P301S and P301L transgenic mice overexpressing the human tau mutated gene, and evaluated the therapeutic effects of a tau oligomer monoclonal antibody (TOMA). We found that retinal edema and breakdown of blood–retina barrier were observed at the very early stage of tauopathy. Leukocyte adhesion/infiltration, and microglial recruitment/activation were constantly increased in the retinal ganglion cell layer of tau transgenic mice at different ages, while Müller cell gliosis was only detected in relatively older tau mice. Concomitantly, the number and function of RGCs progressively decreased during aging although they were not considerably altered in the very early stage of tauopathy. Moreover, intrinsically photosensitive RGCs appeared more sensitive to tauopathy. Remarkably, TOMA treatment in young tau transgenic mice significantly attenuated vascular leakage, inflammation and RGC loss. Our data provide compelling evidence that abnormal tau accumulation can lead to pathology in the retinal NVU, and vascular alterations occur more manifest and earlier than neurodegeneration in the retina. Oligomeric tau-targeted immunotherapy has the potential to treat tau-induced retinopathies. These data suggest that retinal NVU may serve as a potential biomarker for diagnosis and staging of tauopathy as well as a platform to study the molecular mechanisms of neurodegeneration. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40478-021-01149-y. |
format | Online Article Text |
id | pubmed-7992935 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-79929352021-03-25 Early alterations of neurovascular unit in the retina in mouse models of tauopathy Xia, Fan Ha, Yonju Shi, Shuizhen Li, Yi Li, Shengguo Luisi, Jonathan Kayed, Rakez Motamedi, Massoud Liu, Hua Zhang, Wenbo Acta Neuropathol Commun Research The retina, as the only visually accessible tissue in the central nervous system, has attracted significant attention for evaluating it as a biomarker for neurodegenerative diseases. Yet, most of studies focus on characterizing the loss of retinal ganglion cells (RGCs) and degeneration of their axons. There is no integrated analysis addressing temporal alterations of different retinal cells in the neurovascular unit (NVU) in particular retinal vessels. Here we assessed NVU changes in two mouse models of tauopathy, P301S and P301L transgenic mice overexpressing the human tau mutated gene, and evaluated the therapeutic effects of a tau oligomer monoclonal antibody (TOMA). We found that retinal edema and breakdown of blood–retina barrier were observed at the very early stage of tauopathy. Leukocyte adhesion/infiltration, and microglial recruitment/activation were constantly increased in the retinal ganglion cell layer of tau transgenic mice at different ages, while Müller cell gliosis was only detected in relatively older tau mice. Concomitantly, the number and function of RGCs progressively decreased during aging although they were not considerably altered in the very early stage of tauopathy. Moreover, intrinsically photosensitive RGCs appeared more sensitive to tauopathy. Remarkably, TOMA treatment in young tau transgenic mice significantly attenuated vascular leakage, inflammation and RGC loss. Our data provide compelling evidence that abnormal tau accumulation can lead to pathology in the retinal NVU, and vascular alterations occur more manifest and earlier than neurodegeneration in the retina. Oligomeric tau-targeted immunotherapy has the potential to treat tau-induced retinopathies. These data suggest that retinal NVU may serve as a potential biomarker for diagnosis and staging of tauopathy as well as a platform to study the molecular mechanisms of neurodegeneration. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40478-021-01149-y. BioMed Central 2021-03-24 /pmc/articles/PMC7992935/ /pubmed/33762004 http://dx.doi.org/10.1186/s40478-021-01149-y Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Xia, Fan Ha, Yonju Shi, Shuizhen Li, Yi Li, Shengguo Luisi, Jonathan Kayed, Rakez Motamedi, Massoud Liu, Hua Zhang, Wenbo Early alterations of neurovascular unit in the retina in mouse models of tauopathy |
title | Early alterations of neurovascular unit in the retina in mouse models of tauopathy |
title_full | Early alterations of neurovascular unit in the retina in mouse models of tauopathy |
title_fullStr | Early alterations of neurovascular unit in the retina in mouse models of tauopathy |
title_full_unstemmed | Early alterations of neurovascular unit in the retina in mouse models of tauopathy |
title_short | Early alterations of neurovascular unit in the retina in mouse models of tauopathy |
title_sort | early alterations of neurovascular unit in the retina in mouse models of tauopathy |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992935/ https://www.ncbi.nlm.nih.gov/pubmed/33762004 http://dx.doi.org/10.1186/s40478-021-01149-y |
work_keys_str_mv | AT xiafan earlyalterationsofneurovascularunitintheretinainmousemodelsoftauopathy AT hayonju earlyalterationsofneurovascularunitintheretinainmousemodelsoftauopathy AT shishuizhen earlyalterationsofneurovascularunitintheretinainmousemodelsoftauopathy AT liyi earlyalterationsofneurovascularunitintheretinainmousemodelsoftauopathy AT lishengguo earlyalterationsofneurovascularunitintheretinainmousemodelsoftauopathy AT luisijonathan earlyalterationsofneurovascularunitintheretinainmousemodelsoftauopathy AT kayedrakez earlyalterationsofneurovascularunitintheretinainmousemodelsoftauopathy AT motamedimassoud earlyalterationsofneurovascularunitintheretinainmousemodelsoftauopathy AT liuhua earlyalterationsofneurovascularunitintheretinainmousemodelsoftauopathy AT zhangwenbo earlyalterationsofneurovascularunitintheretinainmousemodelsoftauopathy |